Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2018

01-10-2018 | Original article

Alcohol consumption and incidence of proteinuria: a retrospective cohort study

Authors: Yoshiki Kimura, Ryohei Yamamoto, Maki Shinzawa, Yoshitaka Isaka, Kunitoshi Iseki, Kunihiro Yamagata, Kazuhiko Tsuruya, Hideaki Yoshida, Shouichi Fujimoto, Koichi Asahi, Toshiki Moriyama, Tsuyoshi Watanabe

Published in: Clinical and Experimental Nephrology | Issue 5/2018

Login to get access

Abstract

Background

Previous studies report conflicting results of a dose-dependent association between alcohol consumption and incidence of chronic kidney disease. Only a few studies have assessed the clinical impact of > 45–65 g/day of critically high alcohol consumption.

Methods

This retrospective cohort study included 88,647 males and 88,925 females with dipstick urinary protein ≤ ± and estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2 at their first annual health examinations between April 2008 and March 2010 in Japan. The exposure was the self-reported alcohol consumption. The outcome was proteinuria defined as dipstick urinary protein ≥ 1 + or ≥ 2 +.

Results

During median 1.8 years (interquartile range 1.0–2.1) of the observational period, 5416 (6.1%) males and 3262 (3.7%) females developed proteinuria defined as dipstick urinary protein ≥ 1 +. In males, a U-shape association between alcohol consumption and proteinuria was observed in a multivariable-adjusted Poisson regression model [incidence rate ratio (95% confidence interval) of rare, occasional, and daily drinkers with ≤ 19, 20–39, 40–59, and ≥ 60 g/day: 1.00 (reference), 0.86 (0.79–0.94), 0.70 (0.64–0.78), 0.82 (0.75–0.90), 1.00 (0.90–1.11), and 1.00 (0.85–1.17), respectively], whereas a J-shape association was observed in females [1.00 (reference), 0.81 (0.75–0.87), 0.74 (0.64–0.85), 0.93 (0.78–1.11), 1.09 (0.83–1.44), and 1.45 (1.02–2.08), respectively]. Similar associations with dipstick urinary protein ≥ 2 + were shown in males and females.

Conclusions

Moderate alcohol consumption was associated with lower risk of proteinuria in both males and females. Females with ≥ 60 g/day of high alcohol consumption were at higher risk of proteinuria, whereas males were not. Females were more vulnerable to high alcohol consumption, than males.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.CrossRefPubMedPubMedCentral Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.CrossRefPubMedPubMedCentral
2.
go back to reference Gmel G, Gutjahr E, Rehm J. How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis. Eur J Epidemiol. 2003;18:631–42.CrossRefPubMed Gmel G, Gutjahr E, Rehm J. How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis. Eur J Epidemiol. 2003;18:631–42.CrossRefPubMed
3.
go back to reference Di Castelnuovo A. Alcohol Dosing and Total Mortality in Men and Women. Arch Intern Med. 2006;166:2437.CrossRefPubMed Di Castelnuovo A. Alcohol Dosing and Total Mortality in Men and Women. Arch Intern Med. 2006;166:2437.CrossRefPubMed
4.
go back to reference Wang C, Xue H, Wang Q, Hao Y, Li D, Gu D, et al. Effect of drinking on all-cause mortality in women compared with men: a meta-analysis. J Women’s Heal. 2014;23:373–81.CrossRef Wang C, Xue H, Wang Q, Hao Y, Li D, Gu D, et al. Effect of drinking on all-cause mortality in women compared with men: a meta-analysis. J Women’s Heal. 2014;23:373–81.CrossRef
5.
go back to reference Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T. Do “Moderate” drinkers have reduced mortality risk? A systematic review and meta-analysis of alcohol consumption and all-cause mortality. J Stud Alcohol Drugs. 2016;77:185–98.CrossRefPubMedPubMedCentral Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T. Do “Moderate” drinkers have reduced mortality risk? A systematic review and meta-analysis of alcohol consumption and all-cause mortality. J Stud Alcohol Drugs. 2016;77:185–98.CrossRefPubMedPubMedCentral
6.
go back to reference Gunzerath L, Faden V, Zakhari S, Warren K. National Institute on alcohol abuse and alcoholism report on moderate drinking. Alcohol Clin Exp Res. 2004;28:829–47.CrossRefPubMed Gunzerath L, Faden V, Zakhari S, Warren K. National Institute on alcohol abuse and alcoholism report on moderate drinking. Alcohol Clin Exp Res. 2004;28:829–47.CrossRefPubMed
7.
go back to reference Rehm J, Baliunas D, Borges GLG, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105:817–43.CrossRefPubMedPubMedCentral Rehm J, Baliunas D, Borges GLG, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105:817–43.CrossRefPubMedPubMedCentral
8.
go back to reference Reynolds K, Lewis B, Nolen JDL, Kinney GL, Sathya B, He J, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579–88.CrossRefPubMed Reynolds K, Lewis B, Nolen JDL, Kinney GL, Sathya B, He J, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579–88.CrossRefPubMed
9.
go back to reference Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali W. a. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671–1.CrossRefPubMedPubMedCentral Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali W. a. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671–1.CrossRefPubMedPubMedCentral
10.
go back to reference Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types - a systematic review and meta-analysis. BMC Public Health. 2010;10:258.CrossRefPubMedPubMedCentral Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types - a systematic review and meta-analysis. BMC Public Health. 2010;10:258.CrossRefPubMedPubMedCentral
11.
go back to reference Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes: A meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719–25.CrossRefPubMed Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes: A meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719–25.CrossRefPubMed
12.
go back to reference Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a Risk Factor for Type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32:2123–32.CrossRefPubMedPubMedCentral Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a Risk Factor for Type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32:2123–32.CrossRefPubMedPubMedCentral
13.
go back to reference Li X-H, Yu F-F, Zhou Y-H, He J. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. Am J Clin Nutr. 2016;103:818–29.CrossRefPubMed Li X-H, Yu F-F, Zhou Y-H, He J. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. Am J Clin Nutr. 2016;103:818–29.CrossRefPubMed
14.
go back to reference Huang J, Wang X, Zhang Y. Specific types of alcoholic beverage consumption and risk of type 2 diabetes: a systematic review and meta-analysis. J Diabetes Investig. 2017;8:56–68.CrossRefPubMed Huang J, Wang X, Zhang Y. Specific types of alcoholic beverage consumption and risk of type 2 diabetes: a systematic review and meta-analysis. J Diabetes Investig. 2017;8:56–68.CrossRefPubMed
15.
go back to reference Yang Y, Liu D-C, Wang Q-M, Long Q-Q, Zhao S, Zhang Z, et al. Alcohol consumption and risk of coronary artery disease: a dose-response meta-analysis of prospective studies. Nutrition. 2016;32:637–44.CrossRefPubMed Yang Y, Liu D-C, Wang Q-M, Long Q-Q, Zhao S, Zhang Z, et al. Alcohol consumption and risk of coronary artery disease: a dose-response meta-analysis of prospective studies. Nutrition. 2016;32:637–44.CrossRefPubMed
16.
go back to reference Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–90.CrossRefPubMed Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–90.CrossRefPubMed
17.
go back to reference Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2010;17:706–12.CrossRefPubMedPubMedCentral Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2010;17:706–12.CrossRefPubMedPubMedCentral
18.
go back to reference Kodama S, Saito K, Tanaka S, Horikawa C, Saito A, Heianza Y, et al. Alcohol consumption and risk of atrial fibrillation. J Am Coll Cardiol. 2011;57:427–36.CrossRefPubMed Kodama S, Saito K, Tanaka S, Horikawa C, Saito A, Heianza Y, et al. Alcohol consumption and risk of atrial fibrillation. J Am Coll Cardiol. 2011;57:427–36.CrossRefPubMed
19.
go back to reference Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, et al. Alcohol, tobacco and breast cancer—collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87:1234–45.CrossRefPubMed Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, et al. Alcohol, tobacco and breast cancer—collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87:1234–45.CrossRefPubMed
20.
go back to reference Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer. 2015;112:580–93.CrossRefPubMed Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer. 2015;112:580–93.CrossRefPubMed
21.
go back to reference Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011;22:1958–72.CrossRefPubMed Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011;22:1958–72.CrossRefPubMed
22.
go back to reference Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Brabec BA, O’Corragain OA, Edmonds PJ, et al. High alcohol consumption and the risk of renal damage: a systematic review and meta-analysis. QJM An Int J Med. 2015;108:539–48.CrossRef Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Brabec BA, O’Corragain OA, Edmonds PJ, et al. High alcohol consumption and the risk of renal damage: a systematic review and meta-analysis. QJM An Int J Med. 2015;108:539–48.CrossRef
23.
go back to reference Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.CrossRefPubMed Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.CrossRefPubMed
24.
go back to reference Uehara S, Hayashi T, Kogawa Sato K, Kinuhata S, Shibata M, Oue K, et al. Relationship between alcohol drinking pattern and risk of proteinuria: the Kansai Healthcare Study. J Epidemiol. 2016;26:464–70.CrossRefPubMed Uehara S, Hayashi T, Kogawa Sato K, Kinuhata S, Shibata M, Oue K, et al. Relationship between alcohol drinking pattern and risk of proteinuria: the Kansai Healthcare Study. J Epidemiol. 2016;26:464–70.CrossRefPubMed
25.
go back to reference White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009;24:2464–72.CrossRefPubMed White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009;24:2464–72.CrossRefPubMed
26.
go back to reference Koning SH, Gansevoort RT, Mukamal KJ, Rimm EB, Bakker SJL, Joosten MM. Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 2015;87:1009–16.CrossRefPubMed Koning SH, Gansevoort RT, Mukamal KJ, Rimm EB, Bakker SJL, Joosten MM. Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 2015;87:1009–16.CrossRefPubMed
27.
go back to reference Buja A, Scafato E, Baggio B, Sergi G, Maggi S, Rausa G, et al. Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian Longitudinal Study on Aging (ILSA). Public Health Nutr. 2011;14:1907–18.CrossRefPubMed Buja A, Scafato E, Baggio B, Sergi G, Maggi S, Rausa G, et al. Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian Longitudinal Study on Aging (ILSA). Public Health Nutr. 2011;14:1907–18.CrossRefPubMed
28.
go back to reference Sato KK, Hayashi T, Uehara S, Kinuhata S, Oue K, Endo G, et al. Drinking pattern and risk of chronic kidney disease: The Kansai Healthcare Study. Am J Nephrol. 2014;40:516–22.CrossRefPubMed Sato KK, Hayashi T, Uehara S, Kinuhata S, Oue K, Endo G, et al. Drinking pattern and risk of chronic kidney disease: The Kansai Healthcare Study. Am J Nephrol. 2014;40:516–22.CrossRefPubMed
29.
go back to reference Terawaki H, Nakayama M, Asahi K, Kakamu T, Hayakawa T, Iseki K, et al. Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation. Clin Exp Nephrol. 2015;19:387–94.CrossRefPubMed Terawaki H, Nakayama M, Asahi K, Kakamu T, Hayakawa T, Iseki K, et al. Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation. Clin Exp Nephrol. 2015;19:387–94.CrossRefPubMed
30.
go back to reference Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population. Am J Kidney Dis. 2015;66:972–83.CrossRefPubMed Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population. Am J Kidney Dis. 2015;66:972–83.CrossRefPubMed
31.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefPubMed
34.
go back to reference Schaeffner ES. Alcohol Consumption and the Risk of Renal Dysfunction in Apparently Healthy Men. Arch Intern Med. 2005;165:1048.CrossRefPubMed Schaeffner ES. Alcohol Consumption and the Risk of Renal Dysfunction in Apparently Healthy Men. Arch Intern Med. 2005;165:1048.CrossRefPubMed
35.
go back to reference Menon V, Katz R, Mukamal K, Kestenbaum B, de Boer IH, Siscovick DS, et al. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant. 2010;25:3301–7.CrossRefPubMedPubMedCentral Menon V, Katz R, Mukamal K, Kestenbaum B, de Boer IH, Siscovick DS, et al. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant. 2010;25:3301–7.CrossRefPubMedPubMedCentral
36.
go back to reference Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73:870–6.CrossRefPubMed Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73:870–6.CrossRefPubMed
37.
go back to reference Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107:1246–60.CrossRefPubMedPubMedCentral Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107:1246–60.CrossRefPubMedPubMedCentral
38.
go back to reference Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens. 2012;14:792–8.CrossRef Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens. 2012;14:792–8.CrossRef
39.
go back to reference Ammon E, Schäfer C, Hofmann U, Klotz U. Disposition and first-pass metabolism of ethanol in humans: Is it gastric or hepatic and does it depend on gender? Clin Pharmacol Ther. 1996;59:503–13.CrossRefPubMed Ammon E, Schäfer C, Hofmann U, Klotz U. Disposition and first-pass metabolism of ethanol in humans: Is it gastric or hepatic and does it depend on gender? Clin Pharmacol Ther. 1996;59:503–13.CrossRefPubMed
40.
go back to reference Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001;25:502–7.CrossRefPubMed Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001;25:502–7.CrossRefPubMed
41.
go back to reference Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. N Engl J Med. 1990;322:95–9.CrossRefPubMed Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. N Engl J Med. 1990;322:95–9.CrossRefPubMed
42.
go back to reference McCarthy ET, Zhou J, Eckert R, Genochio D, Sharma R, Oni O, et al. Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE. Prostaglandins Other Lipid Mediat. 2015;116–117:88–98.CrossRefPubMed McCarthy ET, Zhou J, Eckert R, Genochio D, Sharma R, Oni O, et al. Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE. Prostaglandins Other Lipid Mediat. 2015;116–117:88–98.CrossRefPubMed
43.
go back to reference Toda A, Ishizaka Y, Tani M, Yamakado M. Current dietary salt intake of Japanese individuals assessed during health check-up. Hypertens Res. 2015;38:163–8.CrossRefPubMed Toda A, Ishizaka Y, Tani M, Yamakado M. Current dietary salt intake of Japanese individuals assessed during health check-up. Hypertens Res. 2015;38:163–8.CrossRefPubMed
44.
go back to reference He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and asian mild hypertensives. Hypertension. 2009;54:482–8.CrossRefPubMed He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and asian mild hypertensives. Hypertension. 2009;54:482–8.CrossRefPubMed
45.
go back to reference Wall TL, Luczak SE, Hiller-Sturmhöfel S. Biology, genetics, and environment: underlying factors influencing alcohol metabolism. Alcohol Res. 2016;38:59–68.PubMedPubMedCentral Wall TL, Luczak SE, Hiller-Sturmhöfel S. Biology, genetics, and environment: underlying factors influencing alcohol metabolism. Alcohol Res. 2016;38:59–68.PubMedPubMedCentral
46.
go back to reference Sen Zhang W, Xu L, Mary Schooling C, Jiang CQ, Keung Cheng K, Liu B, et al. Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study. Hypertens Res. 2013;36:741–6.CrossRefPubMedCentral Sen Zhang W, Xu L, Mary Schooling C, Jiang CQ, Keung Cheng K, Liu B, et al. Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study. Hypertens Res. 2013;36:741–6.CrossRefPubMedCentral
47.
go back to reference Nakagawa T, Kajiwara A, Saruwatari J, Hamamoto A, Kaku W, Oniki K, et al. The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption. Pharmacogenet Genom. 2013;23:34–7.CrossRef Nakagawa T, Kajiwara A, Saruwatari J, Hamamoto A, Kaku W, Oniki K, et al. The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption. Pharmacogenet Genom. 2013;23:34–7.CrossRef
48.
go back to reference Dakeishi M, Murata K, Sasaki M, Tamura A, Iwata T. Association of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotypes with fasting plasma glucose levels in Japanese male and female workers. Alcohol Alcohol. 2008;43:143–7.CrossRefPubMed Dakeishi M, Murata K, Sasaki M, Tamura A, Iwata T. Association of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotypes with fasting plasma glucose levels in Japanese male and female workers. Alcohol Alcohol. 2008;43:143–7.CrossRefPubMed
49.
go back to reference Ferrari P, McKay JD, Jenab M, Brennan P, Canzian F, Vogel U, et al. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr. 2012;66:1303–8.CrossRefPubMed Ferrari P, McKay JD, Jenab M, Brennan P, Canzian F, Vogel U, et al. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr. 2012;66:1303–8.CrossRefPubMed
50.
go back to reference Sluik D, Jankovic N, Hughes M, O’Doherty MG, Schöttker B, Drygas W, et al. Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project. Eur J Clin Nutr. 2017;71:659–68.CrossRefPubMed Sluik D, Jankovic N, Hughes M, O’Doherty MG, Schöttker B, Drygas W, et al. Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project. Eur J Clin Nutr. 2017;71:659–68.CrossRefPubMed
51.
go back to reference Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol. 2011;26:833–50.CrossRefPubMed Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol. 2011;26:833–50.CrossRefPubMed
Metadata
Title
Alcohol consumption and incidence of proteinuria: a retrospective cohort study
Authors
Yoshiki Kimura
Ryohei Yamamoto
Maki Shinzawa
Yoshitaka Isaka
Kunitoshi Iseki
Kunihiro Yamagata
Kazuhiko Tsuruya
Hideaki Yoshida
Shouichi Fujimoto
Koichi Asahi
Toshiki Moriyama
Tsuyoshi Watanabe
Publication date
01-10-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 5/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1568-0

Other articles of this Issue 5/2018

Clinical and Experimental Nephrology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.